Bicara Therapeutics Inc.
BCAX
43 insider filings · Latest: Aug 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 20 8:07 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 15,000 | $20.04 | $300.6K | 362,152(D) | View → |
| May 15, 2026 | May 18 8:24 PM | Ryan CohlheppDirector, President and COO | Sale | 12,500 | $20.29 | $253.6K | 191,641(D) | View → |
| May 18, 2026 | May 18 8:18 PM | Mazumdar Claire | Proposed Sale | 15,000 | $20.92 | $313.8K | — | View → |
| May 15, 2026 | May 15 8:14 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $20.31 | $253.9K | — | View → |
| Apr 27, 2026 | Apr 28 11:49 PM | David RabenChief Medical Officer | Sale | 5,500 | $22.88 | $125.8K | 55,286(D) | View → |
| Apr 27, 2026 | Apr 27 8:09 PM | Raben David | Proposed Sale | 5,500 | $22.88 | $125.8K | — | View → |
| Apr 21, 2026 | Apr 22 8:53 PM | Ivan HyepChief Financial Officer | Sale | 9,200 | $23.00 | $211.6K | 145,355(D) | View → |
| Apr 21, 2026 | Apr 21 8:09 PM | Hyep Ivan | Proposed Sale | 9,200 | $23.18 | $213.2K | — | View → |
| Apr 20, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 15,000 | $23.61 | $354.1K | 362,152(D) | View → |
| Apr 20, 2026 | Apr 20 8:02 PM | Mazumdar Claire | Proposed Sale | 15,000 | $23.74 | $356.1K | — | View → |
| Apr 15, 2026 | Apr 17 8:55 PM | Ryan CohlheppDirector, President and COO | Sale | 12,500 | $23.01 | $287.6K | 196,141(D) | View → |
| Apr 15, 2026 | Apr 15 8:06 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $22.98 | $287.3K | — | View → |
| Mar 25, 2026 | Mar 26 11:21 PM | David RabenChief Medical Officer | Sale | 5,500 | $18.95 | $104.2K | 55,286(D) | View → |
| Mar 25, 2026 | Mar 25 8:01 PM | Raben David | Proposed Sale | 5,500 | $18.95 | $104.2K | — | View → |
| Mar 23, 2026 | Mar 24 11:45 PM | Ivan HyepChief Financial Officer | Sale | 9,200 | $18.52 | $170.3K | 145,355(D) | View → |
| Mar 23, 2026 | Mar 23 8:04 PM | Hyep Ivan | Proposed Sale | 9,200 | $18.60 | $171.1K | — | View → |
| Mar 20, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 1,596 | $18.95 | $30.2K | 339,392(D) | View → |
| Mar 19, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 6,905 | $18.78 | $129.7K | 339,392(D) | View → |
| Mar 18, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 6,499 | $18.84 | $122.4K | 339,392(D) | View → |
| Mar 20, 2026 | Mar 20 8:08 PM | Mazumdar Claire | Proposed Sale | 1,596 | $18.95 | $30.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Aug 14 8:54 PM | Jennifer LarsonChief Financial Officer | Grant/Award | 285,000 | $24.63 | 285,000(D) | View → |
| Aug 10, 2026 | Aug 12 8:19 PM | Ivan HyepChief Financial Officer | Option Exercise | 12,500 | $3.79 | 26,336(D) | View → |
| Aug 10, 2026 | Aug 12 8:19 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 10,000 | $3.79 | 110,546(D) | View → |
| Aug 10, 2026 | Aug 12 8:19 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 18,750 | $3.79 | 51,752(D) | View → |
| Jul 28, 2026 | Jul 29 8:18 PM | Jeremy BenderDirector | Grant/Award | 38,950 | $26.88 | 38,950(D) | View → |
| Jul 28, 2026 | Jul 29 8:18 PM | Christy J. OligerDirector | Grant/Award | 38,950 | $26.88 | 38,950(D) | View → |
| Jul 10, 2026 | Jul 14 8:22 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 10,000 | $3.79 | 120,546(D) | View → |
| Jul 8, 2026 | Jul 10 8:10 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 18,750 | $3.79 | 70,502(D) | View → |
| Jul 8, 2026 | Jul 10 8:10 PM | Ivan HyepChief Financial Officer | Option Exercise | 12,500 | $3.79 | 38,836(D) | View → |
| Jun 9, 2026 | Jun 10 8:43 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 19,475 | $20.56 | 19,475(I) | View → |
| Jun 9, 2026 | Jun 10 8:35 PM | Christopher BowdenDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:34 PM | Kate HavilandDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:34 PM | Kiran Mazumdar-ShawDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:33 PM | Scott M. RobertsonDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:33 PM | Michael PowellDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:32 PM | Jake SimsonDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| May 21, 2026 | May 26 9:48 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 70,584(D) | View → |
| May 18, 2026 | May 20 8:07 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 15,000 | $3.79 | 146,107(D) | View → |
| May 15, 2026 | May 18 8:24 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 101,334(D) | View → |
| May 8, 2026 | May 12 8:04 PM | William SchelmanChief Medical Officer | Grant/Award | 85,000 | $22.58 | 85,000(D) | View → |
Page 1 of 3
Next →